Regenicin Market Cap

Regenicin has a market cap or net worth of $15.35 thousand as of March 6, 2026. Its market cap has decreased by -99.57% in one year.

Market Cap

15.35K

Enterprise Value

n/a

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.00

Market Cap Chart

Since November 16, 2009, Regenicin's market cap has decreased from 2.17M to 15.35K, a decrease of -99.29%. That is a compound annual growth rate of -26.30%.

Market Cap History

Date	Market Cap	% Change
Feb 2, 2026	15.35K	9,931.37%
Dec 31, 2025	153.00	-99.80%
Dec 29, 2022	76.74K	-95.00%
Dec 31, 2021	1.53M	-33.99%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Q BioMed	14.51K
Scopus BioPharma	16.83K
Virpax Pharmaceuticals	13.79K
ObsEva	11.72K
Health Sciences Group	20.51K
America Great Health	21.15K
Syros Pharmaceuticals	21.47K
Biostax	10.71K

Market Cap Rankings